February 2025 CLL Bloodline
February 1, 2025
February 2025 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
February 2025 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
The combination of sonrotoclax and zanubrutinib was well-tolerated and produced high rates of undetectable disease in patients with treatment-naïve CLL.
Undetectable measurable (minimal) residual disease (uMRD) has strong prognostic significance in CLL and may, in the future, guide the duration of therapy.
Dr. Nicole Lamanna discusses upcoming novel therapies for CLL / SLL from the American Society for Hematology (ASH) annual meeting, a scientific conference.
The American Society for Hematology (ASH) annual meeting is a scientific conference where researchers present their latest findings on blood diseases.
BeiGene and CLL Society partnered on Test Before Treat, educating healthcare providers and CLL / SLL patients about the importance of biomarker testing.
The goal of the CLL Treatment Decision Tool is to increase your understanding of your chronic lymphocytic leukemia (CLL) and your treatment options.
Richter’s transformation is a rare very aggressive complication of CLL. Learn the role of stem cell transplants in treating Richter’s transformation.
People with CLL and SLL are at higher risk of developing infections due to having weakened immune systems.
© 2025 CLL Society. All Rights Reserved.
Legal | Privacy Policy | Corporate Giving Policy
Terms & Conditions | Report a Bug | Site Design
CLL Society Inc. is a patient–centric, physician–curated nonprofit organization focused on patient education, support, and research. Dedicated to addressing the unmet needs of the chronic lymphocytic leukemia (CLL) and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research, and educate providers and patients.
CLL Society is a registered 501(c)(3) tax-exempt nonprofit organization. All donations are tax-deductible to the greatest extent as allowed under federal law. CLL Society’s tax ID number is 46-4131354.
1454 Melrose Avenue, Ste. 1-247
Chula Vista, CA 91911